Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.89516 | 38 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.86879 | 38 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.91796 | 40 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.83858 | 39 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.81863 | 38 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.97008 | 39 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.87822 | 36 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.85637 | 38 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.91376 | 41 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.87789 | 39 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.87548 | 39 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.85357 | 39 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.88303 | 38 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.87594 | 39 |